President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” (the Competition Executive Order), identifies a lack of competition as a key driver for problems across economic sectors. The Report presents principles for equitable drug pricing reform through competition, innovation, and transparency; describes promising legislative approaches; and summarizes actions already underway or under consideration across the Department of Health and Human Services (HHS). In the course of preparing the Report, Secretary Xavier Becerra, other HHS officials, and HHS staff held listening sessions with consumer groups, staff from the Medicare Payment Advisory Commission (MedPAC), independent experts and researchers, and stakeholders from across the health care system.
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Arielle Bosworth, (202) 809-1225, arielle.bosworth@hhs.gov. Content will be updated pending the outcome of the Section 508 review.